Viking Therapeutics, Inc. VKTX
- VK2809 — Metabolic Dysfunction-Associated Steatohepatitis Phase 2
- VK0214 — X-Linked Adrenoleukodystrophy Phase 1
Home › Targets › thyroid hormone receptor beta
Companies with an active program directed at thyroid hormone receptor beta.